Screening of selected genomic areas potentially involved in thyroid neoplasms

European Journal of Cancer

Volumn 37, Issue 18, 2001, Pages 2470-2474

  Oriola, J ^a   Rivera Fillat, F ^a   Halperin, I ^a   Angel, M ^a   Mallofre C ^a   Muntane J ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Follicular thyroid adenoma; Loss of Heterozygosity; Papillary thyroid carcinoma; Tumour supressor gene

Indexed keywords

ARTICLE; CANCER GENETICS; CARCINOGENESIS; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 7Q; CONTROLLED STUDY; ENDOCRINE TUMOR; EPITHELIUM TUMOR; FOLLICULAR CARCINOMA; GENE FREQUENCY; GENE LOCATION; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SCREENING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID ADENOMA; THYROID CARCINOMA; THYROID TUMOR; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADENOMA; CARCINOMA, PAPILLARY; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; DISEASE PROGRESSION; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; GENETIC SCREENING; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; THYROID NEOPLASMS;

EID: 0035197538     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00302-1     Document Type: Article

References (28)

1. Clonal composition of benign and malignant human thyroid tumors
2. Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations
3. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis
4. Ras mutations are uncommon in sporadic thyroid cancer in children and young adults
5. Gsp mutations in human thyroid tumours
6. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
7. PTC is a novel rearranged form of the ret protooncogene and is frequently detected in vivo in human papillary carcinomas
8. Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation
9. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population
10. Unique association of P53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland
11. High prevalence of mutations of the P53 gene in poorly differentiated human thyroid carcinoma
12. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma
13. Chromosome 3p24-26 and 3p22-12 loss in human prostatic adenocarcinoma
14. PAX8-PPARγ1 fusion in oncogene human thyroid carcinoma
15. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors
16. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer
17. Deletion mapping on chromosome 10q25-q26 in human endometrial cancer
18. Allelotyping of follicular thyroid tumors
19. Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors
20. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors
21. An allelotype of papillary thyroid cancer
22. Molecular defects in thyroid gland neoplasia
23. Molecular basis of thyroid cancer
24. Origin and progression of thyroid epithelial tumours: Cellular and molecular mechanisms
25. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction
26. Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23
27. Deletion mapping on chromosome 17p in medulloblastoma
28. Methylation of the HIC-1 candidate tumor supressor gene in human breast cancer